These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37442267)

  • 1. A perspective on In vitro developmental neurotoxicity test assay results: An expert panel review.
    Juberg DR; Fox DA; Forcelli PA; Kacew S; Lipscomb JC; Saghir SA; Sherwin CM; Koenig CM; Hays SM; Kirman CR
    Regul Toxicol Pharmacol; 2023 Sep; 143():105444. PubMed ID: 37442267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An expert-driven literature review of "negative" chemicals for developmental neurotoxicity (DNT) in vitro assay evaluation.
    Martin MM; Baker NC; Boyes WK; Carstens KE; Culbreth ME; Gilbert ME; Harrill JA; Nyffeler J; Padilla S; Friedman KP; Shafer TJ
    Neurotoxicol Teratol; 2022; 93():107117. PubMed ID: 35908584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances and current challenges of new approach methodologies in developmental and adult neurotoxicity testing.
    Serafini MM; Sepehri S; Midali M; Stinckens M; Biesiekierska M; Wolniakowska A; Gatzios A; Rundén-Pran E; Reszka E; Marinovich M; Vanhaecke T; Roszak J; Viviani B; SenGupta T
    Arch Toxicol; 2024 May; 98(5):1271-1295. PubMed ID: 38480536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revolutionizing developmental neurotoxicity testing - a journey from animal models to advanced in vitro systems.
    Smirnova L; Hogberg HT; Leist M; Hartung T
    ALTEX; 2024; 41(2):152-178. PubMed ID: 38579692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Regulatory and Scientific Effort for Improved Developmental Neurotoxicity Testing.
    Sachana M; Bal-Price A; Crofton KM; Bennekou SH; Shafer TJ; Behl M; Terron A
    Toxicol Sci; 2019 Jan; 167(1):45-57. PubMed ID: 30476307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
    Bal-Price A; Pistollato F; Sachana M; Bopp SK; Munn S; Worth A
    Toxicol Appl Pharmacol; 2018 Sep; 354():7-18. PubMed ID: 29476865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity.
    Bal-Price A; Hogberg HT; Crofton KM; Daneshian M; FitzGerald RE; Fritsche E; Heinonen T; Hougaard Bennekou S; Klima S; Piersma AH; Sachana M; Shafer TJ; Terron A; Monnet-Tschudi F; Viviani B; Waldmann T; Westerink RHS; Wilks MF; Witters H; Zurich MG; Leist M
    ALTEX; 2018; 35(3):306-352. PubMed ID: 29485663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How neurobehavior and brain development in alternative whole-organism models can contribute to prediction of developmental neurotoxicity.
    Collins ES; Hessel EVS; Hughes S
    Neurotoxicology; 2024 May; 102():48-57. PubMed ID: 38552718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a regulatory use of alternative developmental neurotoxicity testing (DNT).
    Terron A; Bennekou SH
    Toxicol Appl Pharmacol; 2018 Sep; 354():19-23. PubMed ID: 29454059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
    Fritsche E; Grandjean P; Crofton KM; Aschner M; Goldberg A; Heinonen T; Hessel EVS; Hogberg HT; Bennekou SH; Lein PJ; Leist M; Mundy WR; Paparella M; Piersma AH; Sachana M; Schmuck G; Solecki R; Terron A; Monnet-Tschudi F; Wilks MF; Witters H; Zurich MG; Bal-Price A
    Toxicol Appl Pharmacol; 2018 Sep; 354():3-6. PubMed ID: 29447839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An industry perspective: A streamlined screening strategy using alternative models for chemical assessment of developmental neurotoxicity.
    Li J; Settivari R; LeBaron MJ; Marty MS
    Neurotoxicology; 2019 Jul; 73():17-30. PubMed ID: 30786249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use.
    Aschner M; Ceccatelli S; Daneshian M; Fritsche E; Hasiwa N; Hartung T; Hogberg HT; Leist M; Li A; Mundi WR; Padilla S; Piersma AH; Bal-Price A; Seiler A; Westerink RH; Zimmer B; Lein PJ
    ALTEX; 2017; 34(1):49-74. PubMed ID: 27452664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of neurotoxicology (NT)/developmental neurotoxicology (DNT) adverse outcome pathways and key event linkages with in vitro DNT screening assays.
    Pitzer EM; Shafer TJ; Herr DW
    Neurotoxicology; 2023 Dec; 99():184-194. PubMed ID: 37866692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays.
    Sachana M; Willett C; Pistollato F; Bal-Price A
    Reprod Toxicol; 2021 Aug; 103():159-170. PubMed ID: 34147625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meeting report: alternatives for developmental neurotoxicity testing.
    Lein P; Locke P; Goldberg A
    Environ Health Perspect; 2007 May; 115(5):764-8. PubMed ID: 17520065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zebrafish and nematodes as whole organism models to measure developmental neurotoxicity.
    Hughes S; Hessel EVS
    Crit Rev Toxicol; 2024 May; 54(5):330-343. PubMed ID: 38832580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental neurotoxicity test guidelines: problems and perspectives.
    Tohyama C
    J Toxicol Sci; 2016; 41(Spec):SP69-SP79. PubMed ID: 28250285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating Data From In Vitro New Approach Methodologies for Developmental Neurotoxicity.
    Carstens KE; Carpenter AF; Martin MM; Harrill JA; Shafer TJ; Paul Friedman K
    Toxicol Sci; 2022 Apr; 187(1):62-79. PubMed ID: 35172012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considering developmental neurotoxicity in vitro data for human health risk assessment using physiologically-based kinetic modeling: deltamethrin case study.
    Maass C; Schaller S; Dallmann A; Bothe K; Müller D
    Toxicol Sci; 2023 Mar; 192(1):59-70. PubMed ID: 36637193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of study design and sex-differences on results from developmental neurotoxicity studies of bisphenol A: implications for toxicity testing.
    Beronius A; Johansson N; Rudén C; Hanberg A
    Toxicology; 2013 Sep; 311(1-2):13-26. PubMed ID: 23485653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.